Barclays has downgraded Cigna (CI), citing risks associated with the company's Pharmacy Benefit Manager (PBM) transition. The downgrade signals potential challenges Cigna may face as it navigates this significant operational change.
Barclays' downgrade of Cigna signals potential headwinds for the healthcare company as it undergoes a critical operational change in its Pharmacy Benefit Manager (PBM) segment. Investors will be watching closely to see how Cigna manages this transition and its impact on future earnings.
Barclays' downgrade of Cigna signals potential headwinds for the healthcare company as it undergoes a critical operational change in its Pharmacy Benefit Manager (PBM) segment. Investors will be watching closely to see how Cigna manages this transition and its impact on future earnings.